FLIXOTIDE NEBULES 0.5 MG2 ML Israel - English - Ministry of Health

flixotide nebules 0.5 mg2 ml

glaxo smith kline (israel) ltd - fluticasone propionate - inhalation suspension for nebulisation - fluticasone propionate 0.5 mg / 2 ml - fluticasone - fluticasone - in adults and adolescents over 16 years flixotide nebules can be used:for prophylactic management of severe chronic asthma in patients requiring high dose inhaled or oral corticosteroid therapy. it reduces symptoms and exacerbations of asthma in patients previously treated with other prophylactic therapy.children and adolescents from 4 to 16 years of age:treatment of acute exacerbations of asthma.

FLIXOTIDE NEBULES 2 MG2 ML Israel - English - Ministry of Health

flixotide nebules 2 mg2 ml

glaxo smith kline (israel) ltd - fluticasone propionate - inhalation suspension for nebulisation - fluticasone propionate 2 mg / 2 ml - fluticasone - fluticasone - in adults and adolescents over 16 years flixotide nebules can be used:for prophylactic management of severe chronic asthma in patients requiring high dose inhaled or oral corticosteroid therapy. it reduces symptoms and exacerbations of asthma in patients previously treated with other prophylactic therapy.

Tobramycin 300mg5ml nebuliser liquid ampoules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

tobramycin 300mg5ml nebuliser liquid ampoules

sun pharmaceutical industries europe b.v. - tobramycin - nebuliser liquid - 60mg/1ml

Zerseos 0.5 mg/2.5 mg per 2.5 ml nebuliser solution Ireland - English - HPRA (Health Products Regulatory Authority)

zerseos 0.5 mg/2.5 mg per 2.5 ml nebuliser solution

cipla europe nv - ipratropium bromide monohydrate; salbutamol sulfate - nebuliser solution - 0.5mg/2.5 milligram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salbutamol and sodium cromoglicate

Zerseos 0.5 mg/2.5 mg per 2.5 ml nebuliser solution Ireland - English - HPRA (Health Products Regulatory Authority)

zerseos 0.5 mg/2.5 mg per 2.5 ml nebuliser solution

azure pharmaceuticals ltd - ipratropium bromide monohydrate; salbutamol sulfate - nebuliser solution - 0.5mg/2.5 milligram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salbutamol and sodium cromoglicate

Tymbrineb 300 mg/5 ml Nebuliser Solution Ireland - English - HPRA (Health Products Regulatory Authority)

tymbrineb 300 mg/5 ml nebuliser solution

teva pharma b.v. - tobramycin - nebuliser solution - 300 mg/5ml - other aminoglycosides; tobramycin

Ipramol Steri-Neb 0.5 mg/2.5 mg per 2.5 ml nebuliser solution Ireland - English - HPRA (Health Products Regulatory Authority)

ipramol steri-neb 0.5 mg/2.5 mg per 2.5 ml nebuliser solution

teva b.v. - ipratropium bromide; salbutamol sulfate - nebuliser solution - 0.5/2.5 mg/mg - adrenergics in combination with anticholinergics; salbutamol and ipratropium bromide

Salbutamol Neutec 2.5 mg/2.5 ml nebuliser solution Ireland - English - HPRA (Health Products Regulatory Authority)

salbutamol neutec 2.5 mg/2.5 ml nebuliser solution

neutec inhaler ireland limited - salbutamol sulfate - nebuliser solution - salbutamol

Ipratropium bromide/Salbutamol Neutec 0.5/2.5 mg per 2.5 ml nebuliser solution Ireland - English - HPRA (Health Products Regulatory Authority)

ipratropium bromide/salbutamol neutec 0.5/2.5 mg per 2.5 ml nebuliser solution

neutec inhaler ireland limited - ipratropium bromide monohydrate; salbutamol sulfate - nebuliser solution - salbutamol and ipratropium bromide

Nebulizer, non-heated Australia - English - Department of Health (Therapeutic Goods Administration)

nebulizer, non-heated

medline international two australia pty ltd - 35457 - nebulizer, non-heated - nebulizers are devices that atomize medications to be administered by aerosol therapy to patients